These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 28646513

  • 1. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
    [Abstract] [Full Text] [Related]

  • 2. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW.
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC.
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K, Ren H, Zhang R, Yuan YF, Qian J.
    Zhonghua Yan Ke Za Zhi; 2017 Aug 11; 53(8):570-574. PubMed ID: 28851196
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun 11; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 14. INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.
    Francis JH, Marr BP, Brodie SE, Gobin P, Dunkel IJ, Abramson DH.
    Retin Cases Brief Rep; 2016 Jun 11; 10(4):357-60. PubMed ID: 26630243
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H, Koç İ, Varan A, Akyüz C.
    Eur J Ophthalmol; 2017 Jun 26; 27(4):423-427. PubMed ID: 28106239
    [Abstract] [Full Text] [Related]

  • 16. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar 26; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada GL, Abramson DH.
    Ophthalmology; 2014 Sep 26; 121(9):1810-7. PubMed ID: 24819859
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.